Predicting adult ADHD using an artificial intelligence (AI) diagnosed tool
- Conditions
- attention deficit hyperactivity disorder, ADHD
- Registration Number
- JPRN-UMIN000049863
- Lead Sponsor
- Takeda Pharmaceutical Company Limited.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 113
Not provided
Any subject who meets any of the following criteria will not qualify for entry into the study: -The subject is, in the opinion of the physician, unable to participate in the study due to deafness, dysarthria, aphasia, etc. -Cognitive impairment due to a nervous system disorder (Epilepsy, stroke, etc.) or other disorders such as head trauma, or a diagnosis of dementia -The subject has a diagnosis of ASD. -The subject has a diagnosis of psychiatric illness, including anxiety, obsessive-compulsive and related disorders, traumatic and stress-related disorders, depression, bipolar disorder, schizophrenia spectrum disorder, or limited learning and intellectual disability. -Other cases where the investigator or sub-investigator judges it difficult to continue the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity, specificity, and accuracy of the following AI prediction model
- Secondary Outcome Measures
Name Time Method